Bioengineering in the oral cavity: Our experience

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 3883-3886

  Catalfamo, L ^a   Belli, E ^b   Nava, C ^a   Mici, E ^a   Calvo, A ^a   D'Alessandro, B ^a   De Ponte, F S ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bioengineering; Mucosal recovery; Oral cavity

Indexed keywords

COLLAGEN; HYALURONIC ACID; HYDROGEN PEROXIDE; OXIDIZED REGENERATED CELLULOSE; POVIDONE IODINE;

AGED; ARTICLE; BIOENGINEERING; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EPITHELIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; MOUTH MUCOSA; ORAL MUCOSAL DISEASE; TIME; TREATMENT OUTCOME; WOUND CARE; WOUND HEALING;

BIOENGINEERING; MUCOSAL RECOVERY; ORAL CAVITY;

AGED; BANDAGES; CELLULOSE, OXIDIZED; FEMALE; HUMANS; HYALURONIC ACID; MALE; MOUTH; SOFT TISSUE INJURIES; TREATMENT OUTCOME; WOUND HEALING;

EID: 84885760477     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S47697     Document Type: Article

References (17)

1. Cullen B, Smith R, McCulloch E, Silcock D, Morrison L. Mechanism of action of Promogran, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen. 2002;10:16-25.
2. Guarnera G, Restuccia A. Promogran and complex surgical lesion: a case report. J Wound Care. 2004;13:237-239.
3. Nwomeh BC, Yager DR, Cohen IK. Physiology of the chronic wound. Clin Plast Surg. 1998;25:341-356.
4. Vin F, Teot L, Meaume S. The healing properties of Promogran in venous leg ulcers. J Wound Care. 2002;11:335-341.
5. Ghatnekar O, Willis M, Persson U. Cost-effectiveness of treating deep diabetic foot ulcers with Promogran in four European countries. J Wound Care. 2002;11:70-74.
6. Campoccia D, Doherty P, Radice M, Brun P, Abatangelo G, Williams DF. Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials. 1998;19:2101-2127.
7. Chen WY, Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen. 1999;7:79-89.
8. Clark RAF. Wound repair: overview and general considerations. In: Clark RAF, editor. The Molecular Biology of Wound Repair. 2nd ed. New York, NY: Plenum Press; 1996.
9. Ravanti L, Kähäri VM. Matrix metalloproteinases in wound repair. Int J Mol Med. 2000;6:391-407.
10. Barrick B, Campbell EJ, Owen CA. Leukocyte proteinases in wound healing: roles in physiologic and pathologic processes. Wound Repair Regen. 1999;7:410-422.
11. Vaheri A, Stephens RW, Salonen EM, Pollanen J, Tapiovaara H. Plasminogen activation at the cell surface-matrix interface. Cell Differ Dev. 1990;32:255-262.
12. Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg. 2002;137:822-827.
13. Motta G, Ratto GB, De Barbieri A, et al. Can heterologous collagen enhance the granulation tissue growth? An experimental study. Ital J Surg Sci. 1983;13:101-108.
14. Derbyshire A. The use of combination treatments and dressing for a traumatic wound. Br J Nurs. 2004;13:987-993.
15. Price RD, Das-Gupta V, Leigh IM, Navsaria HA. A comparison of tissue-engineered hyaluronic acid dermal matrices in a human wound model. Tissue Eng. 2006;12:2985-2995.
16. Myers SR, Partha VN, Soranzo C, Price RD, Navsaria HA. Hyalomatrix: a temporary epidermal barrier, hyaluronan delivery, and neodermis induction system for keratinocyte stem cell therapy. Tissue Eng. 2007;13:2733-2741.
17. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science. 1985;228: 1324-1326.